1.承德市中心医院新生儿科 河北 承德 067000
2.沧州市中心医院 河北 沧州 061000
3.承德市妇幼保健院妇产科 河北 承德 067000
殷美乐,女,1993—,医学硕士,主治医师,主要从事新生儿疾病的研究,E⁃mail:18531438981@163.com
刘咏梅,女,1985—,主治医师,主要从事新生儿疾病的研究,E⁃mail:15231686601@163.com
收稿:2024-08-20,
纸质出版:2025-10-25
移动端阅览
殷美乐,殷雨来,桑艳峰等.1990—2021年中国和全球新生儿败血症疾病负担变化趋势与预测[J].武汉大学学报(医学版),2025,46(10):1307-1314.
YIN Meile,YIN Yulai,SANG Yanfeng,et al.Trend and prediction analysis of the changing disease burden of neonatal sepsis in China and globally from 1990 to 2021[J].Medical Journal of Wuhan University,2025,46(10):1307-1314.
殷美乐,殷雨来,桑艳峰等.1990—2021年中国和全球新生儿败血症疾病负担变化趋势与预测[J].武汉大学学报(医学版),2025,46(10):1307-1314. DOI: 10.14188/j.1671-8852.2024.0628.
YIN Meile,YIN Yulai,SANG Yanfeng,et al.Trend and prediction analysis of the changing disease burden of neonatal sepsis in China and globally from 1990 to 2021[J].Medical Journal of Wuhan University,2025,46(10):1307-1314. DOI: 10.14188/j.1671-8852.2024.0628.
目的
2
比较分析1990—2021年中国和全球新生儿败血症(NS)的疾病负担变化趋势,涵盖发病率、患病率、死亡率和伤残调整生命年(DALYs)的变化情况,对比和预测未来15年中国与全球的NS疾病负担。
方法
2
基于1990—2021年全球疾病负担数据库(GBD)的公开数据,分析中国与全球NS发病率、患病率、死亡率及DALYs的变化趋势。使用Joinpoint方法计算平均年百分比变化(AAPC)及其95%置信区间(95%
CI
)评估NS疾病负担的变化趋势,从年龄、性别、时间等多个角度对中国与全球的NS疾病负担进行全面对比,并采用自回归积分移动平均(ARIMA)模型预测未来15年中国与全球NS的疾病负担情况。
结果
2
1990—2021年,中国NS的年龄标准化发病率(ASIR)从26.069/10万降至16.754/10万,而全球的ASIR从78.980/10万降至62.701/10万。中国的NS年龄标准化患病率(ASPR)从41.220/10万上升至46.488/10万,而全球ASPR从93.545/10万增加至125.865/10万。中国的NS年龄标准化死亡率(ASMR)从0.727/10万下降至0.246/10万,而全球ASMR从4.766/10万降至3.756/10万。中国的NS年龄标准化DALY率(ASDR)从76.351/10万降至35.674/10万,而全球的ASDR从450.006/10万降至370.547/10万。中国的ASIR、ASPR、ASMR和ASDR的AAPC分别为-0.7%、1.0%、-0.8%和-0.6%,而全球则分别为-1.4%、0.4%、-3.5%和-2.4%。性别对NS的疾病负担有一定影响,表现为男性新生儿的疾病负担重于女性新生儿,这种性别差异在中国尤为明显。未来15年,中国NS的整体疾病负担预计将继续下降;全球范围内,NS的ASIR可能上升,但ASMR预计将下降;这种变化在男女新生儿群体中表现出一致性。
结论
2
1990—2021年,中国NS的疾病负担逐渐减轻,而全球的NS疾病负担则呈先加重后减轻的趋势;中国和全球的NS死亡率和DALY均有所下降;男性新生儿的疾病负担较女性新生儿更为严重。
Objective
2
To compare and analyze the trends in the disease burden of neonatal sepsis (NS) in China and globally from 1990 to 2021
covering the changes in incidence
prevalence
mortality
and disability⁃adjusted life years (DALYs)
and to compare and project the disease burden of NS in China and globally in the next 15 years.
Methods
2
Global Burden of Diseas
e (GBD) database spanning 1990 to 2021 was used to analyze the trends in incidence
prevalence
mortality
and DALYs related to NS in China and globally. The Joinpoint method was used to calculate the average annual percent change (AAPC) and its corresponding 95% confidence interval (95%
CI
) to assess the temporal trends in the burden of NS. A comprehensive comparative analysis of the burden of NS in China and globally was conducted across various dimensions
including age
gender
and period. Moreover
an Autoregressive Integrated Moving Average (ARIMA) model was applied to forecast the NS burden in China and globally for the next 15 years.
Results
2
From 1990 to 2021
the age⁃standardized incidence rate (ASIR) of NS in China declined from 26.069 per 100 000 to 16.754 per 100 000
whereas the global ASIR decreased from 78.980 per 100 000 to 62.701 per 100 000. In China
the age⁃standardized prevalence rate (ASPR) of NS increased from 41.220 per 100 000 to 46.488 per 100 000
while globally
the ASPR rose from 93.545 per 100 000 to 125.865 per 100 000. The age⁃standardized mortality rate (ASMR) of NS in China dropped from 0.727 per 100 000 to 0.246 per 100 000
and globally
it decreased from 4.766 per 100 000 to 3.756 per 100 000. The age⁃standardized DALY rate (ASDR) in China fell from 76.351 per 100 000 to 35.674 per 100 000
while the global ASDR declined from 450.006 per 100 000 to 370.547 per 100 000. The AAPCs for ASIR
ASPR
ASMR
and ASDR in China were -0.7%
1.0%
-0.8%
and -0.6%
respectively
compared to -1.4%
0.4%
-3.5%
and -2.4% globally. Gender differences were observed
with male neonates bearing a heavier disease burden than female neonates
a disparity more pronounced in China. Over the next 15 years
the overall burden of NS in China is expected to continue decreasing; however
while the global ASIR may rise
the global ASMR is anticipated to decline. These trends are consistent across both male and female neonates.
Conclusion
2
Between 1990 and 2021
the disease burden of NS in China progressively lessened
whereas globally
the burden initially increased before subsequently decreasing. The concurrent decline in both mortality and DALYs related to NS in China and globally. A greater disease burden in male neonates compared to female neonates.
LI J , SHEN L , QIAN K . Global, regional, and national incidence and mortality of neonatal sepsis and other neonatal infections, 1990⁃2019 [J ] . Front Public Health , 2023 , 11 : 1139832 .
HENSLER E , PETROS H , GRAY C C , et al . The neonatal innate immune response to sepsis: Checkpoint proteins as novel mediators of this response and as possible therapeutic/diagnostic levers [J ] . Front Immunol , 2022 , 13 : 940930 .
MILTON R , GILLESPIE D , DYER C , et al . Neonatal sepsis and mortality in low⁃income and middle⁃income countries from a facility⁃based birth cohort: An international multisite prospective observational study [J ] . Lancet Glob Health , 2022 , 10 ( 5 ): e661 ⁃e672.
POPESCU C R , CAVANAGH M M M , Tembo B , et al . Neonatal sepsis in low⁃income countries: Epidemiology, diagnosis and prevention [J ] . Expert Rev Anti Infect Ther , 2020 , 18 ( 5 ): 443 ⁃ 452 .
FLANNERY D D , MUKHOPADHYAY S , MORALES K H , et al . Delivery characteristics and the risk of early⁃onset neonatal sepsis [J ] . Pediatrics , 2022 , 149 ( 2 ): e2021052900 .
DONG Y , BASMACI R , TITOMANLIO L , et al . Neonatal sepsis: Within and beyond China [J ] . Chin Med J , 2020 , 133 ( 18 ): 2219 ⁃ 2228 .
WU Y H , XIA F , CHEN M S , et al . Disease burden and attributable risk factors of neonatal disorders and their specific causes in China from 1990 to 2019 and its prediction to 2024 [J ] . BMC Public Health , 2023 , 23 ( 1 ): 122 .
中华医学会儿科学分会新生儿学组 , 中华儿科杂志编辑委员会 . 新生儿败血症诊断与治疗专家共识(2024) [J ] . 中华儿科杂志 , 2024 , 62 ( 10 ): 931 ⁃ 940 .
Chinese Medical Association Pediatric Society Neonatology Group , Editorial Board of Chinese Journal of Pediatrics . Expert consensus on diagnosis and management of neonatal bacteria sepsis (2024) [J ] . Chin J Pediatr , 2024 , 62 ( 10 ): 931 ⁃ 940 .
TAN D J H , SETIAWAN V W , NG C H , et al . Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH [J ] . Hepatology , 2023 , 77 ( 4 ): 1150 ⁃ 1163 .
BRAY F , FERLAY J , SOERJOMATARAM I , et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2018 , 68 ( 6 ): 394 ⁃ 424 .
Global Burden of Disease Cancer Collaboration , FITZMAURICE C , ABATE D , et al . Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability⁃adjusted life⁃years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study [J ] . JAMA Oncol , 2019 , 5 ( 12 ): 1749 ⁃ 1768 .
ZHANG Y , LIU J L , HAN X , et al . Long⁃term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age⁃period⁃cohort analysis based on GBD 2019 [J ] . Front Public Health , 2022 , 10 : 994619 .
LI Y , NING Y C , SHEN B , et al . Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019 [J ] . Clin Kidney J , 2022 , 16 ( 2 ): 312 ⁃ 321 .
LOU H R , WANG X , GAO Y , et al . Comparison of ARIMA model, DNN model and LSTM model in predicting disease burden of occupational pneumoconiosis in Tianjin, China [J ] . BMC Public Health , 2022 , 22 ( 1 ): 2167 .
ZHU B W , WANG Y M , ZHOU W R , et al . Trend dynamics of gout prevalence among the Chinese population, 1990⁃2019: A joinpoint and age⁃period⁃cohort analysis [J ] . Front Public Health , 2022 , 10 : 1008598 .
KAINTH D , PRAKASH S , SANKAR M J . Diagnostic performance of machine learning⁃based models in neonatal sepsis: A systematic review [J ] . Pediatr Infect Dis J , 2024 , 43 ( 9 ): 889 ⁃ 901 .
LI J , XIANG L L , CHEN X S , et al . Global, regional, and national burden of neonatal sepsis and other neonatal infections, 1990⁃2019: Findings from the Global Burden of Disease Study 2019 [J ] . Eur J Pediatr , 2023 , 182 ( 5 ): 2335 ⁃ 2343 .
BETHOU A , BHAT B V . Neonatal sepsis⁃newer insights [J ] . Indian J Pediatr , 2022 , 89 ( 3 ): 267 ⁃ 273 .
SHEN M H , LIANG X X , WU Y S , et al . Estimates of inpatient admission rates and associated costs for infants before and after China's universal two⁃child policy [J ] . BMC Health Serv Res , 2022 , 22 ( 1 ): 163 .
WU X M , DU J Q , LI L C , et al . Bayesian age⁃period⁃cohort prediction of mortality of type 2 diabetic kidney disease in China: A modeling study [J ] . Front Endocrinol , 2021 , 12 : 767263 .
HE Q Y , MOK T N , SIN T H , et al . Global, regional, and national prevalence of gout from 1990 to 2019: Age⁃period⁃cohort analysis with future burden prediction [J ] . JMIR Public Health Surveill , 2023 , 9 : e45943 .
0
浏览量
17
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621